1. Home
  2. IMNN vs ABTS Comparison

IMNN vs ABTS Comparison

Compare IMNN & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • ABTS
  • Stock Information
  • Founded
  • IMNN 1982
  • ABTS 2010
  • Country
  • IMNN United States
  • ABTS Hong Kong
  • Employees
  • IMNN N/A
  • ABTS N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • IMNN Health Care
  • ABTS Technology
  • Exchange
  • IMNN Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • IMNN 12.1M
  • ABTS 9.8M
  • IPO Year
  • IMNN 1985
  • ABTS N/A
  • Fundamental
  • Price
  • IMNN $0.52
  • ABTS $5.41
  • Analyst Decision
  • IMNN Buy
  • ABTS
  • Analyst Count
  • IMNN 2
  • ABTS 0
  • Target Price
  • IMNN $14.00
  • ABTS N/A
  • AVG Volume (30 Days)
  • IMNN 1.3M
  • ABTS 50.3K
  • Earning Date
  • IMNN 08-13-2025
  • ABTS 08-16-2025
  • Dividend Yield
  • IMNN N/A
  • ABTS N/A
  • EPS Growth
  • IMNN N/A
  • ABTS N/A
  • EPS
  • IMNN N/A
  • ABTS N/A
  • Revenue
  • IMNN N/A
  • ABTS $6,711,225.00
  • Revenue This Year
  • IMNN N/A
  • ABTS N/A
  • Revenue Next Year
  • IMNN N/A
  • ABTS N/A
  • P/E Ratio
  • IMNN N/A
  • ABTS N/A
  • Revenue Growth
  • IMNN N/A
  • ABTS 299.11
  • 52 Week Low
  • IMNN $0.37
  • ABTS $1.35
  • 52 Week High
  • IMNN $3.65
  • ABTS $14.10
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 35.40
  • ABTS 61.51
  • Support Level
  • IMNN $0.70
  • ABTS $4.11
  • Resistance Level
  • IMNN $0.86
  • ABTS $6.08
  • Average True Range (ATR)
  • IMNN 0.07
  • ABTS 0.59
  • MACD
  • IMNN -0.03
  • ABTS 0.13
  • Stochastic Oscillator
  • IMNN 0.05
  • ABTS 73.84

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.

Share on Social Networks: